VIBRA-TABS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Vibra-tabs, and when can generic versions of Vibra-tabs launch?
Vibra-tabs is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in VIBRA-TABS is doxycycline hyclate. There are twenty-eight drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vibra-tabs
A generic version of VIBRA-TABS was approved as doxycycline hyclate by CARIBE HOLDINGS on November 8th, 1982.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VIBRA-TABS?
- What are the global sales for VIBRA-TABS?
- What is Average Wholesale Price for VIBRA-TABS?
Summary for VIBRA-TABS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 55 |
| Patent Applications: | 438 |
| DailyMed Link: | VIBRA-TABS at DailyMed |
US Patents and Regulatory Information for VIBRA-TABS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | VIBRA-TABS | doxycycline hyclate | TABLET;ORAL | 050533-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
